The product would reverse the effects of chemicals that disrupt nerve function for military and other emergency situations.
Image: Bob Kramer is president and CEO of Emergent BioSolutions. COURTESY EMERGENT BIOSOLUTIONS
{iframe}https://www.bizjournals.com/washington/news/2019/09/26/emergent-lands-20m-contract-to-develop-chemical.html{/iframe}